ProCE Banner Activity

CE / CME

Prurigo Nodularis: A Look at What’s to Come

PCE On Demand Live Presentation

Prurigo nodularis (PN) is a rare disease that is commonly underrecognized and misdiagnosed. It may be the result of several underlying conditions, but it is a distinct clinical entity that requires its own diagnosis and treatment plan.  In this webcast, Benjamin Ungar, MD provides steps for appropriate diagnosis and discusses current and emerging treatment options for patients with PN.

Nurses: 0.50 Nursing contact hours, includes 0.50 hour of pharmacology credit (0.05 CEUs)

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Physicians: Maximum of 0.50 AMA PRA Category 1 Credit

Released: November 21, 2022

Expiration: November 20, 2023

Share

Faculty

Victoria Garcia-Albea

Victoria Garcia-Albea, PNP, DCNP, MSN, BSN, PRN

Director
Lahey Dermatology Nurse Practitioner Training Program
Lahey Hospital and Medical Center
Burlington, Massachusetts

Benjamin Ungar

Benjamin Ungar, MD

Assistant Professor
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

ProCE Banner
ProCE Banner
ProCE Banner

Supporters

This activity is supported by an educational grant from

Regeneron Pharmaceuticals, Inc

Sanofi

Target Audience

Dermatologists, and NPs, PAs, physicians, and nurses who practice in dermatology

Disclosure

All faculty and planners participating in continuing education activities sponsored by Clinical Care Options, LLC (CCO) and Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to CCO and PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Victoria Garcia-Albea, NP, DCNP: consultant/advisor/speaker: Sanofi-Genzyme.

Kristine Kucera, PA-C, MPAS, DHSc: consultant/advisor/speaker: AbbVie, Amgen, Beiersdorf, Bristol-Myers Squibb, Dermavant, Leo, Novartis, Sun, UCB.

Benjamin Ungar, MD: consultant/advisor/speaker: Arcutis, Castle Biosciences; researcher: Incyte, Pfizer, Rapt Therapeutics.

The planners and content peer reviewers from Clinical Care Options, LLC, Partners for Advancing Clinical Education, and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose, except Victoria Garcia-Albea, NP, DCNP, and Kristine Kucera, PA-C, MPAS, DHSc, as noted above.

Instructions for Credit

Learners wishing to earn CE/CME credit must: 

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete evaluation form 

The estimated time to complete this activity is 0.50 hours.

Release date: November 21, 2022
Expiration date: November 20, 2023

Format

This activity has been made available online.

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Clinical Care Options, LLC, Partners for Advancing Clinical Education, Practicing Clinicians Exchange,  or any educational supporter.

Accreditation

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 0.50, which includes 0.50 hours of pharmacology credit

NP course advisor: Victoria Garcia-Albea, NP, DCNP, Lahey Hospital and Medical Center, Burlington, Massachusetts

 

AAPA Credit Designation

Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until November 20, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Kristine Kucera, PA-C, MPAS, DHSc, UT Southwestern Medical Center, Dallas Texas

 

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credits for learning and change.

Additional Information

Program Medium

This program has been made available online.